Federated Hermes’s Aurinia Pharmaceuticals AUPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $568K | Buy |
67,015
+27
| +0% | +$229 | ﹤0.01% | 1304 |
|
|
2025
Q1 | $539K | Buy |
66,988
+17,629
| +36% | +$142K | ﹤0.01% | 1282 |
|
|
2024
Q4 | $443K | Buy |
49,359
+49,355
| +1,233,875% | +$443K | ﹤0.01% | 1347 |
|
|
2024
Q3 | $29 | Buy |
4
+3
| +300% | +$22 | ﹤0.01% | 2033 |
|
|
2024
Q2 | $6 | Hold |
1
| – | – | ﹤0.01% | 2010 |
|
|
2024
Q1 | $5 | Buy |
+1
| New | +$5 | ﹤0.01% | 2010 |
|
|
2023
Q1 | – | Sell |
-80,481
| Closed | -$348K | – | 2123 |
|
|
2022
Q4 | $348K | Buy |
80,481
+80,174
| +26,115% | +$346K | ﹤0.01% | 1447 |
|
|
2022
Q3 | $2K | Sell |
307
-127,490
| -100% | -$831K | ﹤0.01% | 1960 |
|
|
2022
Q2 | $1.28M | Buy |
127,797
+19,496
| +18% | +$196K | ﹤0.01% | 1051 |
|
|
2022
Q1 | $1.34M | Buy |
108,301
+81,716
| +307% | +$1.01M | ﹤0.01% | 1149 |
|
|
2021
Q4 | $608K | Sell |
26,585
-47,231
| -64% | -$1.08M | ﹤0.01% | 1428 |
|
|
2021
Q3 | $1.63M | Sell |
73,816
-85,710
| -54% | -$1.9M | ﹤0.01% | 1101 |
|
|
2021
Q2 | $2.07M | Buy |
159,526
+30,318
| +23% | +$393K | ﹤0.01% | 1084 |
|
|
2021
Q1 | $1.68M | Buy |
129,208
+15,176
| +13% | +$197K | ﹤0.01% | 1172 |
|
|
2020
Q4 | $1.58M | Buy |
114,032
+8,015
| +8% | +$111K | ﹤0.01% | 1154 |
|
|
2020
Q3 | $1.56M | Buy |
+106,017
| New | +$1.56M | ﹤0.01% | 1077 |
|